US drug approvals
24 approvals with a product on the US market
- Venlafaxine Hydrochloride ANDA220619 · approved 6 Nov 2026
- Diltiazem Hydrochloride ANDA220590 · approved 25 Sep 2026
- Bupropion Hydrochloride ANDA220529 · approved 4 May 2026
- Desvenlafaxine Succinate ANDA220460 · approved 10 Mar 2026
- Micafungin Sodium ANDA219518 · approved 24 Feb 2026
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.